Company intelligence / Profile preview

Cellmedix

Las Vegas, Nevada, United States
Ownership
Private
Development stage
Other
01

Overview

Pharmacokinetic studies demonstrate enhanced bioavailability compared to standard creams, gels, and patches, with systemic bioavailability achieved for therapeutic proteins and biologics

Therapeutic areas
ImmunologyRheumatologyInfectious DiseasesNeurologyDermatology
Modalities
Transdermal drug deliveryTopical formulationProtein deliveryBiologic delivery
Industry
Biotech
02

Partnerships

University of Arizona (Research collaboration)University of Arizona College of Medicine (Research collaboration)

Beyond the preview

Go deeper on Cellmedix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellmedix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call